Buy Lyra Therapeutics Stock | LYRA Stock Price & Latest News | Public
LYRA

Lyra Therapeutics

$0.00 (0.00%)Today

    About LYRA

    Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.37
    -0.56
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.41

    Actual EPS
    Q3 2020

    Stats

    Market Cap$154,7M
    Volume936
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$22.00
    1 Year Low$10.44
    Open$11.77
    High$11.96
    Low$11.37

    Buy any stock with any amount of money.

    Download the App
    Download the app